Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Edvard Smith

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Methods in Enzymology|March 9, 2002
Bioplex technology: novel synthetic gene delivery system based on peptides anchored to nucleic acidsLars J Brandén, C I Edvard Smith
Human Vaccines & Immunotherapeutics|February 21, 2014
Safety and efficacy of DNA vaccines: plasmids vs. minicirclesSofia Stenler, Pontus Blomberg, C I Edvard Smith
Human Mutation|September 14, 2006
BTKbase: the mutation database for X-linked agammaglobulinemiaJouni Väliaho, C I Edvard Smith, Mauno Vihinen
Clinical Immunology Communications|April 15, 2024
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiencyHannes Lindahl, C I Edvard Smith, Peter Bergman
Lakartidningen|January 29, 2025
[Gene editing is changing the treatment of hereditary diseases]C I Edvard Smith, Rula Zain, Pontus Blomberg
Human Gene Therapy|July 11, 2015
Oligonucleotide Therapies: The Past and the PresentKarin E Lundin, Olof Gissberg, C I Edvard Smith
Frontiers in Immunology|December 10, 2021
Editorial: New Insights on Bruton's Tyrosine Kinase InhibitorsC I Edvard Smith, Jennifer R Brown, Rula Zain
International Journal of Molecular Sciences|November 27, 2024
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and CancerC I Edvard Smith, Jan A Burger, Rula Zain
Iscience|July 20, 2022
Estimating the number of diseases - the concept of rare, ultra-rare, and hyper-rareC I Edvard Smith, Peter Bergman, Daniel W Hagey
Immunology Today|October 8, 2014
Strategies for codon usage in human VH familiesP G Olsson, L Hammarström, C I Edvard Smith
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Methods in Enzymology|March 9, 2002
Bioplex technology: novel synthetic gene delivery system based on peptides anchored to nucleic acidsLars J Brandén, C I Edvard Smith
Human Vaccines & Immunotherapeutics|February 21, 2014
Safety and efficacy of DNA vaccines: plasmids vs. minicirclesSofia Stenler, Pontus Blomberg, C I Edvard Smith
Human Mutation|September 14, 2006
BTKbase: the mutation database for X-linked agammaglobulinemiaJouni Väliaho, C I Edvard Smith, Mauno Vihinen
Clinical Immunology Communications|April 15, 2024
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiencyHannes Lindahl, C I Edvard Smith, Peter Bergman
Lakartidningen|January 29, 2025
[Gene editing is changing the treatment of hereditary diseases]C I Edvard Smith, Rula Zain, Pontus Blomberg
Human Gene Therapy|July 11, 2015
Oligonucleotide Therapies: The Past and the PresentKarin E Lundin, Olof Gissberg, C I Edvard Smith
Frontiers in Immunology|December 10, 2021
Editorial: New Insights on Bruton's Tyrosine Kinase InhibitorsC I Edvard Smith, Jennifer R Brown, Rula Zain
International Journal of Molecular Sciences|November 27, 2024
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and CancerC I Edvard Smith, Jan A Burger, Rula Zain
Iscience|July 20, 2022
Estimating the number of diseases - the concept of rare, ultra-rare, and hyper-rareC I Edvard Smith, Peter Bergman, Daniel W Hagey
Immunology Today|October 8, 2014
Strategies for codon usage in human VH familiesP G Olsson, L Hammarström, C I Edvard Smith
Pageof 19